How to Taper Off Wellbutrin (Bupropion) Safely

Linda Girgis | MD

Medically reviewed by Linda Girgis | MD, Girgis Family Medicine on September 4th, 2026.

Published on September 3rd, 2026. Updated on September 4th, 2026.

General 6 min

Key takeaways

  • Bupropion withdrawal risk is real but lower than SSRIs, yet abrupt high-dose stopping raises seizure risk.

  • No single taper schedule fits everyone because dose, formulation, and medical history all matter.

  • XL and SR tablets must never be split, which limits gradual stepping without a new prescription.

  • Distinguishing withdrawal from depression relapse is the hardest part, and a daily mood log helps.

  • Supplements and cold-turkey online advice are not supported by evidence specific to bupropion.

Does Bupropion Actually Cause Withdrawal?

Bupropion does carry a real, if relatively modest, withdrawal risk. Compared to SSRIs and SNRIs, stopping it tends to be gentler for most people, but that does not mean you can simply quit without a plan. The most medically serious reason to taper rather than stop cold turkey is a small but real increased seizure risk when high doses are discontinued abruptly. For your own comfort and safety, a gradual step-down is the smarter move.

Bupropion works differently from most antidepressants. It blocks the reuptake of dopamine and norepinephrine (two brain chemicals tied to energy, motivation, and mood) rather than serotonin. That is why you will not get the "brain zaps" or flu-like sensations that often accompany SSRI discontinuation. What you may notice instead includes:

  • Irritability that feels disproportionate to everyday frustrations
  • Fatigue and low energy, sometimes arriving within two to four days of stopping
  • Dizziness or lightheadedness
  • Mood dips that can be hard to separate from returning depression

Symptoms typically begin within two to four days and peak around the one-week mark. Most resolve on their own within two to four weeks.

What a Standard Bupropion Taper Schedule Looks Like

The general principle is to reduce your dose by no more than 25 to 50 mg every one to two weeks, adjusting the pace based on how well you tolerate each step. Two common paths look like this:

  • 300 mg to 150 mg, then stop (for extended-release formulations)
  • 300 mg to 150 mg to 75 mg (using immediate-release tablets, which allow a smaller final step)

A shorter two to three week taper may be appropriate if you have been on a lower dose for a brief period. A slower four to eight week taper makes more sense if you have taken a higher dose for more than a year, or if your history makes a cautious approach wise.

One important constraint shapes every plan: the formulation you are on.

Formulation

Can tablets be split?

Typical taper flexibility

Practical consideration

IR (immediate-release)

Yes, with care

High, 75 mg steps possible

Most flexible for fine-tuned dose reductions

SR (sustained-release)

No

Moderate, limited by available pill strengths

Splitting destroys the release mechanism and spikes drug levels unsafely

XL (extended-release)

No

Lower, fewer dose increments available

A new prescription for a smaller pill strength is the only safe way to step down

Splitting SR or XL tablets is a commonly suggested workaround online, but it is not safe. Cutting through the coating floods your system with drug too quickly and removes any reliable dose control.

What Should Change Your Taper Plan?

Several factors can call for a slower, more supervised approach.

  • Seizure or eating disorder history. Both significantly raise discontinuation risk. A prescriber-supervised taper, possibly stretched over two months or more, is the standard recommendation.
  • Long duration of use. If you have taken bupropion for more than a year, your brain has had time to adapt, and a longer runway helps it readjust.
  • Higher starting dose. Patients on 450 mg (the maximum approved dose) face more steps and a longer timeline than someone tapering from 150 mg.
  • Active depression or anxiety. Tapering while managing an ongoing condition requires closer monitoring to distinguish withdrawal from a returning illness.

None of these situations makes stopping impossible. They simply mean the plan needs more precision and more check-ins.

What Is Oversold or Simply Does Not Work?

A few ideas circulate widely online that deserve an honest look.

The "bupropion is withdrawal-free" myth. This claim appears in forums and is sometimes repeated by providers. It leads people to stop too quickly and then feel blindsided by irritability and mood crashes. The withdrawal profile is milder than SSRIs, not absent.

Over-the-counter supplements. Omega-3 fatty acids and magnesium are sometimes marketed for antidepressant discontinuation support. The evidence for their use specifically during bupropion tapering is thin to nonexistent. They are not harmful additions, but they should not replace a solid taper plan.

Cold-turkey cessation "just to see." This approach frequently ends with patients restarting their medication after an uncomfortable week, having gained nothing except unnecessary distress and a possible spike in seizure risk at higher doses.

Splitting XL or SR tablets. Covered above, but worth repeating: it creates unpredictable drug levels and should not be done.

How Do You Know If Symptoms Are Withdrawal or Relapse?

This is the hardest question to answer during any taper, and bupropion is no exception. The distinction matters because the responses are different: withdrawal resolves on its own, while relapse typically requires a treatment change.

Here is how the two tend to differ:

  • Withdrawal symptoms arrive within days of a dose reduction, peak around one week, and gradually improve within two to four weeks without new treatment.
  • Relapse signs include the return of your core depressive or anxiety symptoms after a symptom-free gap, or symptoms that worsen steadily beyond the four-week mark.

Keeping a simple daily mood log, just a number from one to ten and a single sentence, gives your clinician concrete information to work with at follow-up. Patterns on paper are far more useful than trying to recall how you felt three weeks ago.

Call your provider immediately if you notice any of the following:

  • New or worsening thoughts of suicide or self-harm
  • A seizure or convulsion
  • Symptoms that are not improving at all after three weeks

These situations are not a normal part of tapering and require prompt medical attention.

Working With a Provider to Stop Safely

A self-managed taper without any provider involvement is possible for some people at lower doses with no complicating history, but it carries real risk for others. A prescriber can write for a smaller pill strength when XL or SR formulations make home splitting impossible, monitor labs or clinical status, and adjust the plan if a step proves too difficult.

When you speak with your prescriber, consider asking:

  • What specific dose reductions do you recommend, and at what intervals?
  • What symptoms should prompt me to slow the taper or pause?
  • What is the plan if my mood drops significantly during the process?
  • Do I need an in-person visit, or can we manage this over telehealth?

Telehealth is generally appropriate for straightforward tapers in people with no seizure history and stable mental health. In-person visits are worth considering when seizure risk, an eating disorder, or active psychiatric symptoms are part of the picture.

Doctronic, the first AI legally authorized to practice medicine, offers 24/7 consultations and $39 video visits with licensed clinicians, making it easier to get timely guidance as you move through each step of your taper. With over 22 million AI consultations completed, the platform can help you prepare the right questions and flag concerning symptoms quickly.

Frequently Asked Questions

Most discontinuation symptoms appear within two to four days of stopping, peak around one week, and resolve within two to four weeks. Symptoms lasting longer than a month may signal relapse rather than withdrawal and deserve a clinician's evaluation.

A lower dose like 150 mg carries less risk than higher doses, but stopping abruptly can still cause irritability, fatigue, and mood dips. A brief two to three week taper is generally the safer and more comfortable choice for most people.

Common bupropion discontinuation symptoms include irritability, fatigue, dizziness, headache, and low mood. These typically begin within two to four days of stopping. A seizure after abrupt high-dose discontinuation is rare but the most serious possible symptom.

Yes. Bupropion affects dopamine and norepinephrine rather than serotonin, so it lacks the "brain zaps" and flu-like symptoms common with SSRI discontinuation. Its overall withdrawal profile is milder, though irritability and mood dips are still reported.

Self-managed tapers carry real risk, especially for anyone with a seizure or eating disorder history. A provider can write dose instructions for smaller steps, monitor for relapse, and respond quickly if symptoms become severe or worrying.

The Bottom Line

Tapering off bupropion is manageable for most people, but it works best with an individualized plan rather than a generic schedule. The dose you are on, how long you have taken it, and your personal health history all shape the safest path. Anyone with a seizure history, an eating disorder, or active depression needs close provider supervision throughout the process. Tracking your mood daily gives your clinician clear information to tell withdrawal apart from relapse. Doctronic offers 24/7 AI-assisted consultations and $39 video visits, giving you around-the-clock access to guidance as you navigate this process. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get personalized health advice

Chat Now